Jose Lutzky, Md

This study tested whether combining two immunotherapy drugs, nivolumab and relatlimab, could shrink tumors in people with metastatic uveal melanoma, a rare and hard-to-treat cancer that starts in the eye and spreads. The trial involved 27 patients who had not received similar tre…